Close Menu

NEW YORK – iCubate said late on Friday that the US Food and Drug Administration cleared the company's assay for detecting and identifying potentially pathogenic gram-negative bacteria associated with bloodstream infection and subsequent sepsis. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.